Company Analysis

Azitra Inc (AZTR)

NYSE: AZTR · Pharmaceutical Preparations · Branford, CT · filing with the SEC since 2017
Grade4.3
◀ Past 1.7● Present 5.5▶ Future 4.9
5 est.

Who runs Azitra Inc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Salva Francisco D.
President and CEO. First filing Jun 2023, latest Jun 18, 2026, 1 filing in all.
Officers reporting now
3
of 5 people with a filing in the last fifteen months
Directors reporting now
2
6 people on the record since 2023
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Salva Francisco D.President and CEOJun 2023Jun 18, 2026none
Staskey NormChief Financial OfficerJun 2023Apr 22, 2026none
Whitfill TravisChief Operating OfficerJun 2023Apr 22, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Ryan BarbaradirectorJun 2023Dec 22, 2025none
Schroer John R.directorJun 2023Dec 22, 2025none
Earlier names on the record21, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton AZTR · research, not advice